justine aaronson - internationalbrain.org · justine aaronson participant has no ... dr. silke...
TRANSCRIPT
Justine Aaronson
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Hosam M. Al-Jehani, MBBS, MSc, FRCSC
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
MS Michelle Sarah Albicini, BPsych (Hons)
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Debra Geraldine Alexander, PhD; MSOC SC Clinical Psychology
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Yvette Alway
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Nada Andelic, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. David B. Arciniegas, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
I will discuss zolpidem treatment of disorders of consciousness.
Prof Philippe Azouvi, MD, PhD
Participant discloses the following financial or non-financial relationships:
1. Allergan: funding for travel accomodation (congress)
Participant has indicated no discussion of unapproved drug or product uses.
Prof Philippe Azouvi
Participant discloses the following financial or non-financial relationships:
1. Allergan: support for congress registration, accommodation and journey
Participant has indicated no discussion of unapproved drug or product uses.
Ms. Shaylea Badovinac
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Ryan Bailey, PhD, OTR/L
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof Georgy Bakalkin, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Mark Theodore Bayley, MD, FRCPC
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Simon Beaulieu-Bonneau
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Gary M. Bedell, PhD, OTR/L
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Silke Bernert, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Jennifer Bogner, PhD, ABPP, FACRM
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Lisa Brenner
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Steven P Broglio, PhD, ATC
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr David Neil Brooks, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Megan Leanne Bruschetta
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Shane S. Bush, PhD, ABPP
Participant discloses the following financial or non-financial relationships:
1. Springer publishing: Royalties
Participant has indicated no discussion of unapproved drug or product uses.
Tamara Bushnik, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof. Johannes Bussmann, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Anne Marie Buunk, MSc
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof. dr. Frans C. T. van der Helm, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Enrico Castelli, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
dr Coriene Catsman-Berrevoets
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Vincy Chan, MPH, PhD Candidate
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Sebastien F Chastin
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Camille Chatelle, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Pearl Chung, M.B.B.S., B.Med.Sci., M.P.H.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Keith Cicerone, PhD, ABPP-Cn, FACRM
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr David Xavier Cifu, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
MSc. Maryse Catharina Cnossen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. John D. Corrigan, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Miss Louise Cottle
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Nikola Creasey
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs Christine Croisiaux
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
i totally agree to indicate unlabled and unapproved uses
Dr Will Curvis, Doctorate in Clinical Psychology
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Kristen Dams-O'Connor
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Rita Liliana de Campos-Pires Santos e Sousa, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Jurriaan De Groot
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Arend de Kloet
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr Peter de Koning, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Erwin De Vlugt
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Carol Di Perri
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Robert Dickinson
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Dara L Dickstein
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Marcel P.J.M. Dijkers, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
PhD Sureyya Dikmen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Thomas P Dompier, PhD, ATC
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Professor Jacinta Douglas, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Dimitrios Drougkas, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
I will refer to the use of transcranial Direct Current Stimulation (tDCS) as an experimental (unlabeled by the
FDA) neurological treatment for Disorders of Consciousness
Dr Nicholas-Tiberio Economou, M.D., MSci, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Henk Jan Eilander, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Cathrine Elisabeth Einarsen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Michael Esterman
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Anna Estraneo
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Linda Ewing-Cobbs, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Philippe Fait, PhD, ATC, CAT(C)
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Joseph J. Fins, M.D., M.A.C.P.
Participant discloses the following financial or non-financial relationships:
1. Cambridge University Press: Book royalties for "Rights Come to Mind: Brain Injury Ethics and the Struggle for
Consciousness"
Participant has indicated the following discussion of unapproved drug or product uses:
Discuss investigational use of deep brain stimulation in MCS under an FDA approved IDE. See Schiff et al
Nature 2007
Prof. Dr. Stefan Ioan Florian
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ms. Kelly Foks, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
dR Rita Formisano
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Rob Forsyth, PhD FRCPCH BM BCh
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Catherine Fortier, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Louis French, Psy.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Valentina Galetto, Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ms Irene Galligan, MISCP
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Professor Sam Gandy, M.D., Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
I will describe the research use of a new PET ligand, T807.
Dr. Joseph Giacino, PhD, FACRM
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Ann Elizabeth Glang, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Jolien Gooijers
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Kate Rachel Gould, DPsych
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Juliet Haarbauer-Krupa, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Biju Hameed, MRCPI MRCPCH PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
The work presented is on the potential neuroprotective effect of steroid receptor antagonists in experimental
models of head injury which include spironolactone and mifepristone, drugs in common use for other
indications.
Dr Firdaus Hariri, MBBS, BDS, MDS(OMFS)
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Tessa Hart, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Karameh Hawash Kuemmerle
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Carol Hawley, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs Claire Hedley
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Lizette Heine, M.Sc
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Allen Heinemann, PhD
Participant discloses the following financial or non-financial relationships:
1. Patient-Centered Outcomes Research Institute (PCORI) Program Award (4201) : Award Winner
Participant has indicated no discussion of unapproved drug or product uses.
Ms Kathy Marie Helmick, MS, CRNP, ANP-BC, CNRN
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Sidney R Hinds, II, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Erin M Holcomb, Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr Mark Holloway, DipSW MA
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr Frank Humle, Director, Neuropsychologist
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Tamerah Hunt
Participant discloses the following financial or non-financial relationships:
1. SLACK, Incorporated: Author
2. USA Football: Serve on the medical advisory board
3. Centers for Disease Control- Nationwide Children's Hospital: Grant recipient
4. National Operating Committee for the Standards of Athletic Equipment (NOCSAE): Grant recipient
Participant has indicated no discussion of unapproved drug or product uses.
Mary Alexis Iaccarino, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Gabriela Ilie, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Harri Isokuortti
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Professor Grant L Iverson, PhD
Participant discloses the following financial or non-financial relationships:
1. NeuroHealth Research and Rehabilitation, Inc.: Independent Practice, Expert Testimony, Consulting
2. NeuroHealth, LLC: Independent Practice, Expert Testimony, Consulting
Participant has indicated no discussion of unapproved drug or product uses.
Dr Peter Owen Jenkins, MA, BMBCh
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Holly Brugge Jimison, PhD, FACMI
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
I will reference any unlabeled/unapproved uses of products. I will not discuss any drugs.
MS Cathy Johnson, B.Sc.,Dip.A.S.S.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ricardo Jorge
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Claire Jourdan, MD, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Mladen Karan, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Ahmed A. Karim
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr Rune Hatlestad Karlsen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
.
Douglas I Katz, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
Amantadine use in patients with DOC
Dr Heather Keenan, MDCM, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Zachary Y Kerr, PhD, MPH
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Bilal Khokhar
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Verena Klamroth-Marganska
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
As I do not work in the US, the product is not FDA certified. instead, I received permission by Swissmedic (the
Swiss agency for the authorisation and supervision of therapeutic products).
Ingerid Kleffelgaard, P.T., MSc
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Sanna Koskinen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Robert G. Kowalski, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
dr Odile Kozlowski Moreau, doctor of physical medicine and
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Denise Krch, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Ryan C Kruse
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Wolfgang Kuehne
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. med. Martin Kulla, M.D. DESA
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ulrich Kunz
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr. Marsh Königs, MSc
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs Marie-Eve Lamontagne, O.T.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
Yes, I intend to reference unlabeled/unapproved uses of drugs or products in my presentation and I agree to
disclose this information to the audience as required by accreditation guidelines.
Amaud Lanthier
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Anne Laurent-Vannier, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Pr. Steven Laureys, M.D.
Participant discloses the following financial or non-financial relationships:
1. Cefaly: Funding
2. G-Tec: Funding
3. Imagilys: Funding
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Jan Lavrijsen, M.D., PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Leon Levi, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Harvey Levin
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Teemu Luoto, M.D. , Ph.D. , Adjunct professor
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Andrew Maas, M.D., PhD
Participant discloses the following financial or non-financial relationships:
1. European Commission, FP-7 framework programme: CENTER-TBI study; grant number 602150-2.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Linda McArthur Maclean, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Veronica Maki-Marttunen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Saafan Malik, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ms. Jennifer Marwitz, M.A.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Simon Robert Mayer
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr Michael Christian Mayinger, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Mazlina Mazlan, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Nicole Mazwi, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Thomas W. McAllister, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
methylphenidate, galantamine
Michael McCrea
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Karen Leigh McCulloch, PT, PhD, NCS
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Brenna McDonald
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Professor Skye McDonald
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Regina McGlinchey, Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Hamish McLeod, PhD CPsychol
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Tom McMillan
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Carel G.M. Meskers
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Peter Meulenbroek, Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Maarten Milders
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr. Mehrbod Mohammadian
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Tatyana Mollayeva, MD, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof. Martin M Monti, Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Daniel Morris
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Risa Nakase-Richardson, PhD, FACRM
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Professor Ponnada Narayana, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Vairavan Narayanan, M.D, FRCSEd (NeuroSurg)
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Karen J. Nolan, PhD
Participant discloses the following financial or non-financial relationships:
1. Ekso Bionics, Inc.: Advisory Board 6-2015
Participant has indicated no discussion of unapproved drug or product uses.
Ms. Rocio Norman, M.A. CCC-SLP
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Lyubov Borisovna Oknina, Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Berno Overbeek
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Llewellyn Padayachy
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Marco YC Pang
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Theresa Pape, Dr.Ph
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Misha Pavel
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Yuri G. Pavlov
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs. Arwen Pel
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs Lianne Peppel, MSc
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof Jennie Louise Ponsford, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
Light therapy for fatigue and melatonin for sleep disturbance following traumatic brain injury
Mr. Shaun Porter, BSc.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs. Ingrid Poulsen, R.N.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Professor Graham Edward Powell
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Aidanas Preiksaitis
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Professor Cathy J Price, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Leslie S Prichep, PhD
Participant discloses the following financial or non-financial relationships:
1. BrainScope Co., Inc.: I serve as Chief Scientific Officer of BrainScope Co., Inc
Participant has indicated no discussion of unapproved drug or product uses.
Dr Kate Radford, PhD, MSc. DipCOT
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Vani Rao, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof Lukas Rasulic, M.D. PhD.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Amit Reches, PhD
Participant discloses the following financial or non-financial relationships:
1. ElMindA: Employee
Participant has indicated no discussion of unapproved drug or product uses.
Gerard M Ribbers, MD, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr David Ripley, MD, MS
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs Cecilie Roe
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Karen G Roos, PhD, MSPT, ATC
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Hemda Rotem
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Kresimir Rotim
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Marc Rousseaux, M.D., Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Durga Roy, MD
Participant discloses the following financial or non-financial relationships:
1. ImmunArray : I am a Co-Investigator on the ImmunArray sponsored study Head Injury Serum Markers for
Assessing Response to Trauma (HeadSMART): IRB00031097
Participant has indicated no discussion of unapproved drug or product uses.
Dr Peter Rumney, MD, FRCPC
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Tomislav Sajko
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
David Salat
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Rajeet Singh Saluja, MD,CM, FRCSC
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Angelle M. Sander, Ph.D., ACRM
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Jaana Maria Sarajuuri, PhD (c)
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ms. Myrthe Elisabeth Scheenen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Nicholas D Schiff, MD
Participant discloses the following financial or non-financial relationships:
1. Enspire DBS, INc: Scientific Advisory Board
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Caroline Schnakers, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Alfred C. Schouten
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs. Trine Schow, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Gregory Scott, MBBS MSc BEng
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ronald Thomas Seel, PhD, FACRM
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Ruud W. Selles
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs Zhanna Semenova, etc, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Mrs Aruna Sharma, MBBS, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr. Bhanu Sharma
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof. David J Sharp, MBBS PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Sandy Shultz, PhD, MSc, BSc
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
A/Prof Grahame K Simpson, MAASW MAPS
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. William Davis Singer, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
Amantadine is not FDA approved for the purpose of this presentation
Elizabeth R. Skidmore, PhD
Participant discloses the following financial or non-financial relationships:
1. San Bio, Inc.: Research Consultant
2. RAND Corporation: Research Consultant
Participant has indicated no discussion of unapproved drug or product uses.
Professor Mark Anthony Slatyer, B.Med Sci (Hons), B.Med,PhD (Med
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Semyon Slobounov
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Agaath Sluijter
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Jonathan David Smirl, PhD.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ms Katherine Price Snedaker, LCSW
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Traci Snedden, PhD, RN, CPNP
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs. Kerstin Spielmann
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
professor dr. Jacoba Margje Spikman, PhD, Clinical Neuropsychologist
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Gershon Spitz, BA, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Dick F. Stegeman, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Joel D Stitzel, Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Irina Strigo, Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Jacek Szczygielski, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ms. Sharon Tamir
Participant discloses the following financial or non-financial relationships:
1. Karyopharm Therapeutics: Employee
Participant has indicated the following discussion of unapproved drug or product uses:
KPT-350
Olli Tenovuo
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
dr Bert Ter Mors, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
I will discuss the investigational use of amantadine in brain injury. For this indication it is off-label use.
(amantadine is approved for the use in influenza-A and Parkinsons disease)
Miss Danielle Tessier
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Aurore Thibaut
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
I will talk about transcranial direct current stimulation (tDCS) which is not FDA approved.
Dr. Marleen C Tjepkema-Cloostermans
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Professor Leanne Togher
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Luigi Trojano
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Jean Luc Truelle, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. David Tulsky, Ph.D.
Participant discloses the following financial or non-financial relationships:
1. TBI-QOL Measures: Copyright holder (non-financial)
2. PROMIS Health Organization: Board of Directors
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Ursula I. Tuor, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Lyn Turkstra, Ph.D., CCC-SLP, BC-ANCDS
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Lynne Turner-Stokes
Participant discloses the following financial or non-financial relationships:
1. Research grant funding: The work n my presentation was funded by a research grant from the NIHR RP-PG-
0407-10185
2. Honoraria: I have received honoraria and lectures fees from Ipsen Pharma
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Andy Tyerman, B.A., M.Sc. Ph.D., C.Psychol.
Participant discloses the following financial or non-financial relationships:
1. Andy Tyerman: Self
2. Ruth Tyerman : Wife
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Gary R Ulicny, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Sebastian van As, Prof, MBChB MBA MMed FCS(SA) PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Coen A.M. van Bennekom, MD, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Crispijn L van den Brand
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
MD Hans van der Horn
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Joukje van der Naalt, M.D. Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Rick Van der Vliet
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Miss Willemijn Sabien van Erp, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Thomas A. Van Essen, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Judith Van Velzen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Erwin van Wegen
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Inge Verlinden
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof Anderson Anne Vicki
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Eirik Vikane, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mrs Martie Vink
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Naznin Virji-Babul, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Marieke M Visser, MSc
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated the following discussion of unapproved drug or product uses:
NA
Dr Victor Volovici, MD
Participant discloses the following financial or non-financial relationships:
1. European Comission Framework 7 Programme: Funding for the department of neurosurgery through the
CENTER-TBI project
Participant has indicated no discussion of unapproved drug or product uses.
Prof. Petar Vulekovic, M.D. Ph.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Amy Kathllen Wagner, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Lorna Wales
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Mr. Colin Wallace, MSc., CAT (C)
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Kevin K. Wang, Ph.D.
Participant discloses the following financial or non-financial relationships:
1. Banyan Biomarkers: Share holder
Participant has indicated no discussion of unapproved drug or product uses.
Dr Yang Wang, MD, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ms. Sarah Wannez
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Gale Whiteneck, PhD, FACRM
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Christopher Thomas Whitlow, MD, PhD, MHA
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. John Whyte, MD, PhD
Participant discloses the following financial or non-financial relationships:
1. LifeMax, Inc.: consultant (fees turned over to employer)
Participant has indicated the following discussion of unapproved drug or product uses:
I intend to discuss the research evidence supporting a range of psychoactive drugs for patients with disorders of
consciousness. There are no labeled indications for this patient population so all treatments are "unlabeled."
Viona J.M. Wijnen, Dr.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Elisabeth Wilde, PhD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Prof. Dr.med. Dieter Heinrich Woischnek, M.D.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Hal Wortzel
Participant discloses the following financial or non-financial relationships:
1. Private practice in Forensic Neuropsychiatry : Private practice in Forensic Neuropsychiatry
Participant has indicated no discussion of unapproved drug or product uses.
Alexander Wright, M.Sc.
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
David Wright
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Tomofumi Yamaguchi, PT
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr Giles Noel Yeates, BSc, MSc, DClinPsych
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Ross Zafonte
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
MSc. Sarah Zandvliet, PT
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Nathan Zasler, MD
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Roger Zemek, M.D., FRCPC
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.
Dr. Barbra Zupan
Participant has no financial or non-financial arrangements or affiliations to disclose.
Participant has indicated no discussion of unapproved drug or product uses.